EP3082957
CANCER TREATMENTS USING COMBINATIONS OF PI3K/AKT PATHWAY AND ERK INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.12.2014EP published:
6.4.2022EP application number:
14871139.3
EPO information:
European Patent Register
Max expiry date:
18.12.2034
Title in English:
CANCER TREATMENTS USING COMBINATIONS OF PI3K/AKT PATHWAY AND ERK INHIBITORSLanguage of the patent:
English
Timeline
Today
19.12.2014EP application
6.4.2022EP Publication
Owner
Name:
Biomed Valley Discoveries, Inc.Address:
4435 Main Street Suite 550, Kansas City, Missouri 64111, US
Inventor
Name:
SAHA, SaurabhAddress:
Wellesley Hills, Massachusetts 02481, US
Name:
WELSCH, DeanAddress:
Parkville, Missouri 64152, US
Name:
DECRESCENZO, GaryAddress:
Parkville, Missouri 64152, US
Name:
ROIX, Jeffrey JamesAddress:
London W1G 7BB, GB
Priority
Number:
201361919638 PDate:
20.12.2013Country:
US
Classification
Categories:
A61P 35/00, A61K 31/5377, A61K 31/4439, A61K 45/06